Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease

BACKGROUND: In Alzheimer’s disease, amyloid- β (A β) peptides aggregate in the lowering CSF amyloid levels - a key pathological hallmark of the disease. However, lowered CSF amyloid levels may also be present in cognitively unimpaired elderly individuals. Therefore, it is of great value to explain t...

Descripción completa

Detalles Bibliográficos
Autores principales: Dansson, Hákon Valur, Stempfle, Lena, Egilsdóttir, Hildur, Schliep, Alexander, Portelius, Erik, Blennow, Kaj, Zetterberg, Henrik, Johansson, Fredrik D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422748/
https://www.ncbi.nlm.nih.gov/pubmed/34488882
http://dx.doi.org/10.1186/s13195-021-00886-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422748/
https://www.ncbi.nlm.nih.gov/pubmed/34488882
http://dx.doi.org/10.1186/s13195-021-00886-5

Ejemplares similares